PerkinElmer Announces Financial Results for the Fourth Quarter of 2013

  • Revenue growth of 4%; Organic revenue growth of 3%
  • GAAP earnings per share from continuing operations of $0.58; Adjusted earnings per share of $0.73
  • Operating income from continuing operations was $85 million; Adjusted operating profit margin increase of 90 basis points driving adjusted earnings per share growth of 12%
  • Operating cash flow from continuing operations of $71 million, up 79%
  • Established full year 2014 guidance range for GAAP earnings per share of $1.93 to $1.98; Adjusted earnings per share guidance range of $2.40 to $2.45

WALTHAM, Mass.--()--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the fourth quarter ended December 29, 2013.

The Company reported GAAP earnings per share from continuing operations of $0.58, compared to a loss of $0.14 in the fourth quarter of 2012. Revenue in the fourth quarter of 2013 was $593.3 million, as compared to $572.9 million in the fourth quarter of 2012. GAAP operating income from continuing operations for the fourth quarter of 2013 was $84.7 million, as compared to an operating loss of $30.8 million in the fourth quarter of 2012, impacted by non-cash charges and other adjustments noted in the Company's reconciliations of non-GAAP financial measures.

Adjusted earnings per share was $0.73, compared to $0.65 in the fourth quarter of 2012. Adjusted revenue for the quarter grew 3% to $594.0 million, compared to $577.0 million in the fourth quarter of 2012. Adjusted operating income for the fourth quarter of 2013 was $114.1 million, compared to $105.6 million for the same period a year ago. Adjusted operating profit margin was 19.2% as a percentage of adjusted revenue, compared to 18.3% for the same period a year ago. Adjustments for the Company's non-GAAP financial measures have been noted in the attached reconciliations.

“We are pleased with our strong finish to the year as we delivered solid performances in adjusted earnings per share growth, adjusted operating margin expansion and operating cash flow generation, ” said Robert Friel, chairman and chief executive officer of PerkinElmer. “By leveraging our recent growth and productivity investments, we are well positioned to deliver a year of profitable revenue growth while continuing to address the critical health and environmental needs of our customers throughout the world.”

2013 Full Year Cash Flow

For the fourth quarter of 2013, operating cash flow from continuing operations was $71.1 million as compared to $39.8 million in the comparable period of 2012. Full year 2013 operating cash flow from continuing operations was $158.1 million as compared to $153.6 million in 2012. The full year 2013 results were impacted by incremental pension contributions, royalty payments and increased working capital uses for the completion of the Company’s productivity initiatives.

Financial Overview by Reporting Segment for the Fourth Quarter of 2013

Human Health

  • Revenue of $336.1 million, as compared to $318.9 million for the fourth quarter of 2012.
  • Adjusted revenue of $336.8 million. Adjusted and organic revenues increased 4%.
  • Operating income of $47.1 million, as compared to an operating loss of $23.8 million for the same period a year ago.
  • Adjusted operating income of $83.8 million. Adjusted operating profit margin was 24.9% as a percentage of adjusted revenue, as compared to 23.9% in the fourth quarter of 2012.

Environmental Health

  • Revenue of $257.2 million, as compared to $254.1 million for the fourth quarter of 2012. Revenue and organic revenue increased 1%.
  • Operating income of $35.1 million, as compared to operating income of $33.9 million for the same period a year ago.
  • Adjusted operating income of $40.8 million. Adjusted operating profit margin was 15.9% as a percentage of revenue, as compared to 15.3% in the fourth quarter of 2012.

Financial Guidance – Full Year 2014

For the full year 2014, the Company forecasts GAAP earnings per share from continuing operations in the range of $1.93 to $1.98 and on a non-GAAP basis, which is expected to include the adjustments noted in the attached reconciliation, adjusted earnings per share of $2.40 to $2.45.

Conference Call Information

The Company will discuss its fourth quarter results and its outlook for business trends in a conference call on January 30, 2014 at 5:00 p.m. Eastern Time (ET). To access the call, please dial (617) 614-4072 prior to the scheduled conference call time and provide the access code 83512237. A playback of this conference call will be available beginning 7:00 p.m. ET, Thursday, January 30, 2014. The playback phone number is (617) 801-6888 and the code number is 82009740.

A live audio webcast of the call will be available on the Investor section of the Company’s Web site, www.perkinelmer.com. Please go to the site at least 15 minutes prior to the call in order to register, download, and install any necessary software. An archived version of the webcast will be posted on the Company’s Web site for a two week period beginning approximately two hours after the call.

Use of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings announcement also contains non-GAAP financial measures. The reasons that we use these measures, a reconciliation of these measures to the most directly comparable GAAP measures, and other information relating to these measures are included below following our GAAP financial statements.

Factors Affecting Future Performance

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities and divestitures. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products declining or not growing as anticipated; (2) fluctuations in the global economic and political environments; (3) our failure to introduce new products in a timely manner; (4) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable, or successfully divest businesses; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials and supplies; (11) the manufacture and sale of products exposing us to product liability claims; (12) our failure to maintain compliance with applicable government regulations; (13) regulatory changes; (14) our failure to comply with healthcare industry regulations; (15) economic, political and other risks associated with foreign operations; (16) our ability to retain key personnel; (17) significant disruption in our information technology systems; (18) our ability to obtain future financing; (19) restrictions in our credit agreements; (20) our ability to realize the full value of our intangible assets; (21) significant fluctuations in our stock price; (22) reduction or elimination of dividends on our common stock; and (23) other factors which we describe under the caption "Risk Factors" in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2.2 billion in 2013, has about 7,600 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

 
PerkinElmer, Inc. and Subsidiaries
CONSOLIDATED INCOME STATEMENTS
                 
 

Three Months Ended

Twelve Months Ended

(In thousands, except per share data)

December 29, 2013

December 30, 2012

December 29, 2013

December 30, 2012

 
 
Revenue $ 593,280 $ 572,921 $ 2,166,232 $ 2,115,205
 
Cost of revenue 317,002 311,263 1,189,258 1,151,999
Selling, general and administrative expenses 141,949 180,708 585,850 632,734
Research and development expenses 32,702 33,538 133,023 132,639
Asset Impairments 6,731 74,153 6,731 74,153
Restructuring and contract termination charges, net   10,215     4,103     33,928     25,137  
 
Operating income (loss) from continuing operations 84,681 (30,844 ) 217,442 98,543
 
Interest income (362 ) (313 ) (650 ) (747 )
Interest expense 14,614 11,651 49,924 45,787
Other expense, net   12,613     558     14,836     2,916  
 
Income (loss) from continuing operations before income taxes 57,816 (42,740 ) 153,332 50,587
 
Benefit from income taxes   (8,184 )   (26,548 )   (12,192 )   (17,854 )
 
Income (loss) from continuing operations 66,000 (16,192 ) 165,524 68,441
 
(Loss) gain on disposition of discontinued operations, before income taxes (2,267 ) 490 (1,810 ) 2,405

(Benefit from) provision for income taxes on discontinued operations and dispositions

  (740 )   154     (1,098 )   906  
 
(Loss) income from discontinued operations and dispositions (1,527 ) 336 (712 ) 1,499
 
Net income (loss) $ 64,473   $ (15,856 ) $ 164,812   $ 69,940  
 
 
Diluted earnings per share:
Income (loss) from continuing operations $ 0.58 $ (0.14 ) $ 1.46 $ 0.60
 
(Loss) income from discontinued operations and dispositions   (0.01 )   0.00     (0.01 )   0.01  
 
Net income (loss) $ 0.57   $ (0.14 ) $ 1.45   $ 0.61  
 
 
Weighted average shares of common stock outstanding 113,463 114,440 113,503 114,860

Diluted

Basic Diluted Diluted
 
ABOVE PREPARED IN ACCORDANCE WITH GAAP
 
                           

Additional Supplemental Information (1):

(per share, continuing operations)
 

GAAP EPS from continuing operations

$ 0.58 $ (0.14 ) $ 1.46 $ 0.60
Amortization of intangible assets, net of income taxes 0.12 0.13 0.51 0.52
Asset impairments, net of income taxes 0.04 0.42 0.04 0.42
Debt extinguishment costs, net of income taxes 0.08 - 0.08 -
Purchase accounting adjustments, net of income taxes 0.02 0.03 0.05 0.16
Acquisition-related costs, net of income taxes 0.00 0.00 0.00 0.01
Significant environmental charges, net of income taxes 0.02 - 0.02 -
Mark to market on postretirement benefits, net of income taxes (0.13 ) 0.19 (0.13 ) 0.20
Restructuring and contract termination charges, net of income taxes 0.05 0.03 0.19 0.16

Significant tax credits

 

(0.06

)

 

-

   

(0.14

)

 

-

 
Adjusted EPS $ 0.73   $ 0.65   $ 2.08   $ 2.06  
 
(1) amounts may not add due to rounding                          
 

 
PerkinElmer, Inc. and Subsidiaries
REVENUE AND OPERATING INCOME (LOSS)
                     
 
 

Three Months Ended

Twelve Months Ended

(In thousands, except percentages)

December 29, 2013

December 30, 2012

December 29, 2013

December 30, 2012

(as adjusted) (as adjusted)
 
Human Health Reported revenue

 

$

336,100

 

$

318,858

 

$

1,209,756

 

$

1,174,642

Purchase accounting adjustments   739     4,076     7,312     26,249  
Adjusted Revenue   336,839     322,934     1,217,068     1,200,891  
 
Reported operating income (loss) from continued operations 47,103 (23,766 ) 146,100 59,196
OP% 14.0 % -7.5 % 12.1 % 5.0 %
Amortization of intangible assets 19,829 19,945 80,217 80,815
Asset impairments 6,731 73,410 6,731 73,410
Purchase accounting adjustments 2,873 4,589 8,919 30,551
Acquisition-related costs - 441 (21 ) 984
Restructuring and contract termination charges, net   7,312     2,544     22,172     17,587  
Adjusted operating income   83,848     77,163     264,118     262,543  
Adjusted OP% 24.9 % 23.9 % 21.7 % 21.9 %
 

Environmental Health

Reported revenue 257,180 254,063 956,476 940,563
Purchase accounting adjustments   -     -     9     -  
Adjusted Revenue   257,180     254,063     956,485     940,563  
 
Reported operating income from continued operations 35,130 33,896 97,052 111,844
OP% 13.7 % 13.3 % 10.1 % 11.9 %
Amortization of intangible assets 2,670 2,549 10,137 10,403
Asset impairments - 743 - 743
Purchase accounting adjustments 50 - 59 -
Acquisition-related costs 16 110 141 204
Restructuring and contract termination charges, net   2,903     1,559     11,756     7,550  
Adjusted operating income   40,769     38,857     119,145     130,744  
Adjusted OP% 15.9 % 15.3 % 12.5 % 13.9 %
 
Corporate Reported operating income (loss) 2,448 (40,974 ) (25,710 ) (72,497 )
Significant environmental charges 4,625 - 4,625 -
Mark to market on postretirement benefits   (17,570 )   30,542     (17,617 )   31,761  
Adjusted operating loss   (10,497 )   (10,432 )   (38,702 )   (40,736 )
 
 

Continuing Operations

Reported revenue

 

$

593,280

 

$

572,921

 

$

2,166,232

 

$

2,115,205

Purchase accounting adjustments   739     4,076     7,321     26,249  

Adjusted revenue

  594,019     576,997     2,173,553     2,141,454  
 
Reported operating income (loss) from continued operations 84,681 (30,844 ) 217,442 98,543
OP% 14.3 % -5.4 % 10.0 % 4.7 %
Amortization of intangible assets 22,499 22,494 90,354 91,218
Asset impairments 6,731 74,153 6,731 74,153
Purchase accounting adjustments 2,923 4,589 8,978 30,551
Acquisition-related costs 16 551 120 1,188
Significant environmental charges 4,625 - 4,625 -
Mark to market on postretirement benefits (17,570 ) 30,542 (17,617 ) 31,761
Restructuring and contract termination charges, net   10,215     4,103     33,928     25,137  
Adjusted operating income

 

$

114,120

 

 

$

105,588

 

 

$

344,561

 

 

$

352,551

 

Adjusted OP%

19.2 % 18.3 % 15.9 % 16.5 %
 
 
REPORTED REVENUE AND REPORTED OPERATING INCOME (LOSS) PREPARED IN ACCORDANCE WITH GAAP
 

 

PerkinElmer, Inc. and Subsidiaries

CONSOLIDATED STATEMENTS OF CASH FLOWS
             
 

Three Months Ended

Twelve Months Ended

December 29, 2013

December 30, 2012

December 29, 2013

December 30, 2012

(In thousands)
 
Operating activities:
Net income (loss) $ 64,473 $ (15,856 ) $ 164,812 $ 69,940
Less: loss (income) from discontinued operations and dispositions, net of income taxes   1,527     (336 )   712     (1,499 )
Income (loss) from continuing operations   66,000     (16,192 )   165,524     68,441  

Adjustments to reconcile income (loss) from continuing operations to net cash provided by continuing operations:

Stock-based compensation 2,630 5,679 14,053 21,031
Restructuring and contract termination charges, net 10,215 4,103 33,928 25,137

Amortization of deferred debt issuance costs, interest rate hedges and accretion of discounts

3,904 862 6,502 3,517
Depreciation and amortization 32,018 32,074 128,471 126,865
Gains on disposition - - (1,566 ) -
Amortization of acquired inventory revaluation - 440 203 5,214
Pension and other postretirement expenses (18,176 ) 35,336 (18,176 ) 35,336
Asset impairments 6,731 74,153 6,731 74,153

Changes in operating assets and liabilities which (used) provided cash, excluding effects from companies purchased and divested:

Accounts receivable, net (41,279 ) (59,714 ) (14,440 ) (44,626 )
Inventories, net 17,931 16,234 (13,851 ) (8,213 )
Accounts payable 4,235 10,735 (1,800 ) (7,876 )
Accrued expenses and other   (13,135 )   (63,912 )   (147,526 )   (145,404 )

Net cash provided by operating activities of continuing operations

  71,074     39,798     158,053     153,575  

Net cash provided by (used in) operating activities of discontinued operations

  629     (274 )   538     (1,405 )

Net cash provided by operating activities

  71,703     39,524     158,591     152,170  
 
Investing activities:
Capital expenditures (7,427 ) (18,058 ) (38,991 ) (42,408 )
Proceeds from dispositions of property, plant and equipment, net - - 52,202 -
Proceeds from surrender of life insurance policies - - 783 -
Changes in restricted cash balances - (183 ) - 487
Activity related to acquisitions and investments, net of cash and cash equivalents acquired   (8,650 )   (34,108 )   (15,699 )   (40,858 )

Net cash used in investing activities of continuing operations

  (16,077 )   (52,349 )   (1,705 )   (82,779 )

Net cash provided by investing activities of discontinued operations

  -     494     494     2,470  

Net cash used in investing activities

  (16,077 )   (51,855 )   (1,211 )   (80,309 )
 

Financing Activities:

Payments on long-term debt

(259,000 ) (102,850 ) (688,000 ) (435,850 )
Proceeds from long-term debt 258,000 104,000 677,000 395,000
Premium on prepayment of debt (11,119 ) - (11,119 ) -
Payments of debt issuance costs - - - (416 )
Settlement of cash flow hedges - 4,050 1,363 4,050
Net (payments on) proceeds from other credit facilities (249 ) 5,417 5,281 5,274
Payments for acquisition-related contingent consideration - - - (12,459 )
Excess tax benefit from exercise of common stock options - - - 1,767
Proceeds from issuance of common stock under stock plans 5,021 9,534 20,313 32,478
Purchases of common stock (212 ) (12 ) (127,398 ) (2,104 )
Dividends paid   (7,867 )   (8,028 )   (31,600 )   (31,903 )

Net cash (used in) provided by financing activities

  (15,426 )   12,111     (154,160 )   (44,163 )
 
Effect of exchange rate changes on cash and cash equivalents   739     836     (1,422 )   1,404  
 

Net increase in cash and cash equivalents

40,939 616 1,798 29,102

Cash and cash equivalents at beginning of period

  132,303     170,828     171,444     142,342  

Cash and cash equivalents at end of period

$ 173,242   $ 171,444   $ 173,242   $ 171,444  
 
 
PREPARED IN ACCORDANCE WITH GAAP
 

 
PerkinElmer, Inc. and Subsidiaries
CONSOLIDATED BALANCE SHEETS
         
 
 

(In thousands)

December 29, 2013

December 30, 2012

 
Current assets:
Cash and cash equivalents $ 173,242 $ 171,444
Accounts receivable, net 470,028 457,011
Inventories, net 261,036 247,688
Other current assets   140,532     95,611  
Total current assets   1,044,838     971,754  
 
Property, plant and equipment, net:
At cost 504,184 513,479
Accumulated depreciation   (318,811 )   (302,963 )
Property, plant and equipment, net 185,373 210,516
Marketable securities and investments 1,319 1,149
Intangible assets, net 460,430 529,901
Goodwill 2,143,120 2,122,788
Other assets, net   111,632     65,654  
Total assets $ 3,946,712   $ 3,901,762  
 
Current liabilities:
Short-term debt $ 2,624 $ 1,772
Accounts payable 167,196 168,943
Short-term accrued restructuring 26,374 21,364
Accrued expenses and other current liabilities 404,064 388,026
Current liabilities of discontinued operations   2,538     995  
Total current liabilities   602,796     581,100  
 
Long-term debt 932,104 938,824
Long-term accrued restructuring 9,161 6,387
Long-term liabilities   410,565     435,639  
Total liabilities   1,954,626     1,961,950  
 
Total stockholders' equity   1,992,086     1,939,812  
Total liabilities and stockholders' equity $ 3,946,712   $ 3,901,762  
 
 
PREPARED IN ACCORDANCE WITH GAAP
 

 

PerkinElmer, Inc. and Subsidiaries

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
                         
(In millions, except per share data and percentages) PKI
Three Months Ended

December 29, 2013

       

December 30, 2012

   
 
Adjusted revenue:
Revenue $ 593.3 $ 572.9
Purchase accounting adjustments   0.7               4.1        
Adjusted revenue $ 594.0             $ 577.0        
 
Adjusted gross margin:
Gross margin $ 276.3 46.6 % $ 261.7 45.7 %
Amortization of intangible assets 13.3 2.2 % 13.1 2.3 %
Purchase accounting adjustments 0.8 0.1 % 4.5 0.8 %
Mark to market on postretirement benefits   0.8       0.1 %       2.5       0.4 %
Adjusted gross margin $ 291.2       49.0 %     $ 281.8       48.8 %
 
Adjusted SG&A:
SG&A $ 141.9 23.9 % $ 180.7 31.5 %
Amortization of intangible assets (9.1 ) -1.5 % (9.3 ) -1.6 %
Purchase accounting adjustments (2.1 ) -0.4 % (0.1 ) 0.0 %
Acquisition-related costs (0.0 ) 0.0 % (0.6 ) -0.1 %
Significant environmental charges (4.6 ) -0.8 % - 0.0 %
Mark to market on postretirement benefits   18.1       3.0 %       (27.9 )     -4.9 %
Adjusted SG&A $ 144.2       24.3 %     $ 142.9       24.8 %
 
Adjusted R&D:
R&D $ 32.7 5.5 % $ 33.5 5.9 %
Amortization of intangible assets (0.1 ) 0.0 % (0.1 ) 0.0 %
Purchase accounting adjustments (0.0 ) 0.0 % - 0.0 %

Mark to market on post retirement benefits

  0.3       0.0 %       (0.2 )     0.0 %
Adjusted R&D $ 32.9       5.5 %     $ 33.3       5.8 %
 
Adjusted operating income:
Operating income (loss) $ 84.7 14.3 % $ (30.8 ) -5.4 %
Amortization of intangible assets 22.5 3.8 % 22.5 3.9 %
Asset impairments 6.7 1.1 % 74.2 12.9 %
Purchase accounting adjustments 2.9 0.5 % 4.6 0.8 %
Acquisition-related costs 0.0 0.0 % 0.6 0.1 %
Significant environmental charges 4.6 0.8 % - 0.0 %
Mark to market on postretirement benefits (17.6 ) -3.0 % 30.5 5.3 %
Restructuring and contract termination charges, net   10.2       1.7 %       4.1       0.7 %
Adjusted operating income $ 114.1       19.2 %     $ 105.6       18.3 %
                   
PKI
Three Months Ended

December 29, 2013

December 30, 2012

 
Adjusted EPS:
GAAP EPS $ 0.57 $ (0.14 )
Discontinued operations, net of income taxes   (0.01 )             0.00        
GAAP EPS from continuing operations 0.58 (0.14 )
Amortization of intangible assets, net of income taxes 0.12 0.13
Asset impairments, net of income taxes 0.04 0.42
Debt extinguishment costs, net of income taxes 0.08 -
Purchase accounting adjustments, net of income taxes 0.02 0.03
Acquisition-related costs, net of income taxes 0.00 0.00
Significant environmental charges, net of income taxes 0.02 -
Mark to market on postretirement benefits, net of income taxes (0.13 ) 0.19
Restructuring and contract termination charges, net of income taxes 0.05 0.03

Significant tax credits

 

(0.06

)

           

-

       
Adjusted EPS $ 0.73             $ 0.65        
                   
Human Health
Three Months Ended

December 29, 2013

December 30, 2012

 
Adjusted revenue:
Revenue $ 336.1 $ 318.9
Purchase accounting adjustments   0.7               4.1        
Adjusted revenue $ 336.8             $ 322.9        
 
Adjusted operating income:
Operating income $ 47.1 14.0 % $ (23.8 ) -7.5 %
Amortization of intangible assets 19.8 5.9 % 19.9 6.3 %
Asset impairments 6.7 2.0 % 73.4 23.0 %
Purchase accounting adjustments 2.9 0.9 % 4.6 1.4 %
Acquisition-related costs - 0.0 % 0.4 0.1 %
Restructuring and contract termination charges, net   7.3       2.2 %       2.5       0.8 %
Adjusted operating income $ 83.8       24.9 %     $ 77.2       23.9 %
                   
Environmental Health
Three Months Ended

December 29, 2013

December 30, 2012

 
Adjusted revenue:
Revenue $ 257.2 $ 254.1
Purchase accounting adjustments   -               -        
Adjusted revenue $ 257.2             $ 254.1        
 
Adjusted operating income:
Operating income $ 35.1 13.7 % $ 33.9 13.3 %
Amortization of intangible assets 2.7 1.0 % 2.5 1.0 %
Asset impairments - 0.0 % 0.7 0.3 %
Purchase accounting adjustments 0.1 0.0 % - 0.0 %
Acquisition-related costs 0.0 0.0 % 0.1 0.0 %
Restructuring and contract termination charges, net   2.9       1.1 %       1.6       0.6 %
Adjusted operating income $ 40.8       15.9 %     $ 38.9       15.3 %
 

 
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
                         

(In millions, except per share data and percentages)

PKI
Twelve Months Ended

December 29, 2013

       

December 30, 2012

   
 
Adjusted revenue:
Revenue $ 2,166.2 $ 2,115.2
Purchase accounting adjustments   7.3               26.2        
Adjusted revenue $ 2,173.6             $ 2,141.5        
 
Adjusted gross margin:
Gross margin $ 977.0 45.1 % $ 963.2 45.5 %
Amortization of intangible assets 53.1 2.5 % 51.8 2.4 %
Purchase accounting adjustments 7.8 0.4 % 31.5 1.5 %
Mark to market on postretirement benefits   0.8       0.0 %       3.7       0.2 %
Adjusted gross margin $ 1,038.6       47.8 %     $ 1,050.2       49.0 %
 
Adjusted SG&A:
SG&A $ 585.9 27.0 % $ 632.7 29.9 %
Amortization of intangible assets

 

(36.9 ) -1.7 % (38.9 ) -1.8 %
Purchase accounting adjustments

 

(1.0 ) 0.0 % 0.9 0.0 %
Acquisition-related costs

 

(0.1 ) 0.0 % (1.2 ) -0.1 %
Significant environmental charges

 

(4.6 ) -0.2 % - 0.0 %
Mark to market on postretirement benefits

 

18.1       0.8 %       (27.9 )     -1.3 %
Adjusted SG&A

$

561.2       25.8 %     $ 565.6       26.4 %
 
Adjusted R&D:
R&D $ 133.0 6.1 % $ 132.6 6.3 %
Amortization of intangible assets (0.3 ) 0.0 % (0.5 ) 0.0 %
Purchase accounting adjustments (0.2 ) 0.0 % - 0.0 %
Mark to market on postretirement benefits   0.3       0.0 %       (0.2 )     0.0 %
Adjusted R&D $ 132.8       6.1 %     $ 132.0       6.2 %
 
Adjusted operating income:
Operating income $ 217.4 10.0 % $ 98.5 4.7 %
Amortization of intangible assets 90.4 4.2 % 91.2 4.3 %
Asset impairments 6.7 0.3 % 74.2 3.5 %
Purchase accounting adjustments 9.0 0.4 % 30.6 1.4 %
Acquisition-related costs 0.1 0.0 % 1.2 0.1 %
Significant environmental charges 4.6 0.2 % - 0.0 %
Mark to market on postretirement benefits (17.6 ) -0.8 % 31.8 1.5 %
Restructuring and contract termination charges, net   33.9       1.6 %       25.1       1.2 %
Adjusted operating income $ 344.6       15.9 %     $ 352.6       16.5 %
                   
PKI
Twelve Months Ended

December 29, 2013

December 30, 2012

 
Adjusted EPS:
GAAP EPS $ 1.45 $ 0.61
Discontinued operations, net of income taxes   (0.01 )             0.01        
GAAP EPS from continuing operations 1.46 0.60
Amortization of intangible assets, net of income taxes 0.51 0.52
Asset impairments, net of income taxes 0.04 0.42
Debt extinguishment costs, net of income taxes 0.08 -
Purchase accounting adjustments, net of income taxes 0.05 0.16
Acquisition-related costs, net of income taxes 0.00 0.01
Significant environmental charges, net of income taxes 0.02 -
Mark to market on postretirement benefits, net of income taxes (0.13 ) 0.20
Restructuring and contract termination charges, net of income taxes 0.19 0.16

Significant tax credits

 

(0.14

)

           

-

       
Adjusted EPS $ 2.08             $ 2.06        
                   
PKI

Twelve Months Ended

December 28, 2014

Adjusted EPS:

Projected

GAAP EPS from continuing operations $

1.93 - $1.98

Amortization of intangible assets, net of income taxes 0.46
Purchase accounting adjustments, net of income taxes 0.01
Restructuring and contract termination charges, net of income taxes              

0.00

       
Adjusted EPS             $

2.40 - $2.45

       
                   

Human Health

Twelve Months Ended

December 29, 2013

December 30, 2012

 
Adjusted revenue:
Revenue $ 1,209.8 $ 1,174.6
Purchase accounting adjustments   7.3               26.2        
Adjusted revenue $ 1,217.1             $ 1,200.9        
 
Adjusted operating income:
Operating income $ 146.1 12.1 % $ 59.2 5.0 %
Amortization of intangible assets 80.2 6.6 % 80.8 6.9 %
Asset impairments 6.7 0.6 % 73.4 6.2 %
Purchase accounting adjustments 8.9 0.7 % 30.6 2.6 %
Acquisition-related costs (0.0 ) 0.0 % 1.0 0.1 %
Restructuring and contract termination charges, net   22.2       1.8 %       17.6       1.5 %
Adjusted operating income $ 264.1       21.7 %     $ 262.5       21.9 %
                   

Environmental Health

Twelve Months Ended

December 29, 2013

December 30, 2012

 
Adjusted revenue:
Revenue $ 956.5 $ 940.6
Purchase accounting adjustments   0.0               -        
Adjusted revenue $ 956.5             $ 940.6        
 
Adjusted operating income:
Operating income $ 97.1 10.1 % $ 111.8 11.9 %
Amortization of intangible assets 10.1 1.1 % 10.4 1.1 %
Purchase accounting adjustments 0.1 0.0 % - 0.0 %
Acquisition-related costs 0.1 0.0 % 0.2 0.0 %
Restructuring and contract termination charges, net   11.8       1.2 %       7.6       0.8 %
Adjusted operating income $ 119.1       12.5 %     $ 130.7       13.9 %
 

 
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
     
 

PKI

Three Months Ended

December 29, 2013

Organic revenue growth:
Reported revenue growth 4%
Less: effect of foreign exchange rates 0%
Less: effect of acquisitions including purchase accounting adjustments 1%
Organic revenue growth 3%
 
 
Human Health
Three Months Ended

December 29, 2013

Organic revenue growth:
Reported revenue growth 5%
Less: effect of foreign exchange rates 0%
Less: effect of acquisitions including purchase accounting adjustments 1%
Organic revenue growth 4%
 
 
Environmental Health
Three Months Ended

December 29, 2013

Organic revenue growth:
Reported revenue growth 1%
Less: effect of foreign exchange rates -1%
Less: effect of acquisitions including purchase accounting adjustments 1%
Organic revenue growth 1%
 

Adjusted Revenue and Adjusted Revenue Growth

We use the term “adjusted revenue” to refer to GAAP revenue, including estimated revenue from contracts acquired in various acquisitions that will not be fully recognized due to business combination accounting rules. We use the related term “adjusted revenue growth” to refer to the measure of comparing current period adjusted revenue with the corresponding period of the prior year. We believe that these non-GAAP measures, when taken together with our GAAP financial measures, allow us and our investors to better measure the performance of our investments in technology, to evaluate long-term performance trends and to assess our ability to invest in our business. Adjusted revenue growth also provides for easier comparisons of our performance with prior and future periods and relative comparisons to our peers. Our GAAP revenue for the periods subsequent to our acquisitions does not reflect the full amount of revenue on such contracts that would have otherwise been recorded by the acquired businesses. The non-GAAP adjustment is intended to reflect the full amount of such revenue. We believe our investors will use this adjustment as a measure of the ongoing performance of the acquired businesses because customers have historically entered into such contracts for renewed and/or developmental support, although there can be no assurance that customers will do so in the future.

Organic Revenue and Organic Revenue Growth

We use the term “organic revenue” to refer to GAAP revenue, excluding the effect of foreign currency translation and acquisitions, and including estimated revenue from contracts acquired in various acquisitions that will not be fully recognized due to business combination accounting rules. We use the related term “organic revenue growth” to refer to the measure of comparing current period organic revenue with the corresponding period of the prior year. We believe that these non-GAAP measures, when taken together with our GAAP financial measures, allow us and our investors to better measure the performance of our investments in technology, to evaluate long-term performance trends and to assess our ability to invest in our business. Organic revenue growth also provides for easier comparisons of our performance with prior and future periods and relative comparisons to our peers. We exclude the effect of foreign currency translation from these measures because foreign currency translation is subject to volatility and can obscure underlying trends. We exclude the effect of acquisitions because acquisition activity can vary dramatically between reporting periods and between us and our peers, which we believe makes comparisons of long-term performance trends difficult for management and investors, and could result in overstating or understating to our investors the performance of our operations. We include estimated revenue from contracts acquired with various acquisitions that will not be fully recognized due to business combination rules. Our GAAP revenue for the periods subsequent to our acquisitions does not reflect the full amount of revenue on such contracts that would have otherwise been recorded by the acquired businesses. The non-GAAP adjustment is intended to reflect the full amount of such revenue. We believe our investors will use this adjustment as a measure of the ongoing performance of the acquired businesses because customers have historically entered into such contracts for renewed and/or developmental support, although there can be no assurance that customers will do so in the future.

Adjusted Gross Margin and Adjusted Gross Margin Percentage

We use the term “adjusted gross margin” to refer to GAAP gross margin, excluding amortization of intangible assets, inventory fair value adjustments related to business acquisitions, other costs related to business acquisitions, and including estimated revenue from contracts acquired in various acquisitions that will not be fully recognized due to business combination accounting rules. We also exclude adjustments for mark-to-market accounting on post-retirement benefits, therefore only our projected costs have been used to calculate our non-GAAP measure. We use the related term “adjusted gross margin percentage” to refer to adjusted gross margin as a percentage of adjusted revenue. We believe that these non-GAAP measures, when taken together with our GAAP financial measures, allow us and our investors to better measure the performance of our investments in technology, to evaluate the long-term profitability trends and to assess our ability to invest in our business. We exclude amortization of intangible assets and adjustments for mark-to-market accounting on post-retirement benefits from these measures because these charges do not represent what we believe our investors consider to be costs of producing our products and could distort the additional value generated over the cost of producing those products. In addition, inventory fair value adjustments related to business acquisitions and other costs related to business acquisitions are excluded because they only occur due to an acquisition and the potential subsequent repositioning of the business that could distort the performance measures of costs used in producing our products. We include estimated revenue from contracts acquired with various acquisitions that will not be fully recognized due to business combination rules. Our GAAP revenue for the periods subsequent to our acquisitions does not reflect the full amount of revenue on such contracts that would have otherwise been recorded by the acquired businesses. The non-GAAP adjustment is intended to reflect the full amount of such revenue. We believe our investors will use this adjustment as a measure of the ongoing performance of the acquired businesses because customers have historically entered into such contracts for renewed and/or developmental support, although there can be no assurance that customers will do so in the future.

Adjusted Selling, General and Administrative (“SG&A”) Expense and Adjusted SG&A Percentage

We use the term “adjusted SG&A expense” to refer to GAAP SG&A expense, excluding amortization of intangible assets, changes to the fair values assigned to contingent consideration, other costs related to business acquisitions, and significant environmental charges. We also exclude adjustments for mark-to-market accounting on post-retirement benefits, therefore only our projected costs have been used to calculate our non-GAAP measure. We use the related term “adjusted SG&A percentage” to refer to adjusted SG&A expense as a percentage of adjusted revenue. We believe that these non-GAAP measures, when taken together with our GAAP financial measures, allow us and our investors to better measure the cost of the internal operating structure, our ability to leverage that structure and the level of investment required to grow our business. We exclude amortization of intangible assets, significant environmental charges, and adjustments for mark-to-market accounting on post-retirement benefits from these measures because these charges do not represent what we believe our investors consider to be costs that support our internal operating structure and could distort the efficiencies of that structure. We exclude changes to the fair values assigned to contingent consideration and other costs related to business acquisitions because they only occur due to an acquisition and the potential subsequent repositioning of the business that could distort the performance measures of costs to support our internal operating structure.

Adjusted Research and Development (“R&D”) Expense and Adjusted R&D Percentage

We use the term “adjusted R&D expense” to refer to GAAP R&D expense, excluding amortization of intangible assets and other costs related to business acquisitions. We also exclude adjustments for mark-to-market accounting on post-retirement benefits, therefore only our projected costs have been used to calculate our non-GAAP measure. We use the related term “adjusted R&D percentage” to refer to adjusted R&D expense as a percentage of adjusted revenue. We believe that these non-GAAP measures, when taken together with our GAAP financial measures, allow us and our investors to better understand and evaluate our internal technology investments. We exclude amortization of intangible assets and adjustments for mark-to-market accounting on post-retirement benefits from these measures because these charges do not represent what we believe our investors consider to be internal investments in R&D activities and could distort our R&D investment level. We exclude other costs related to business acquisitions because they only occur due to an acquisition and the potential subsequent repositioning of the business that could distort the performance measures of costs to support our internal operating structure.

Adjusted Operating Income, Adjusted Operating Profit Percentage, Adjusted Operating Profit Margin and Adjusted Operating Margin

We use the term “adjusted operating income,” to refer to GAAP operating income, excluding amortization of intangible assets, inventory fair value adjustments related to business acquisitions, changes to the fair values assigned to contingent consideration, other costs related to business acquisitions, significant environmental charges, asset impairments, and restructuring and contract termination charges, and including estimated revenue from contracts acquired in various acquisitions that will not be fully recognized due to business combination accounting rules. We also exclude adjustments for mark-to-market accounting on post-retirement benefits, therefore only our projected costs have been used to calculate our non-GAAP measure. Adjusted operating income is calculated by subtracting adjusted R&D expense and adjusted SG&A expense from adjusted gross margin. We use the related terms “adjusted operating profit percentage,” “adjusted operating profit margin,” or “adjusted operating margin” to refer to adjusted operating income as a percentage of adjusted revenue. We believe that these non-GAAP measures, when taken together with our GAAP financial measures, allow us and our investors to analyze the costs of the different components of producing and selling our products, to better measure the performance of our internal investments in technology and to evaluate the long-term profitability trends of our core operations. Adjusted operating income also provides for easier comparisons of our performance and profitability with prior and future periods and relative comparisons to our peers. We believe our investors do not consider the items that we exclude from adjusted operating income to be costs of producing our products, investments in technology and production or costs to support our internal operating structure, and so we present this non-GAAP measure to avoid overstating or understating to our investors the performance of our operations. We exclude asset impairments and restructuring and contract termination charges because they tend to occur due to an acquisition, divestiture, repositioning of the business or other unusual event that could distort the performance measures of our internal investments and costs to support our internal operating structure. We include estimated revenue from contracts acquired with various acquisitions that will not be fully recognized due to business combination rules. Our GAAP revenue for the periods subsequent to our acquisitions does not reflect the full amount of revenue on such contracts that would have otherwise been recorded by the acquired businesses. The non-GAAP adjustment is intended to reflect the full amount of such revenue. We believe our investors will use this adjustment as a measure of the ongoing performance of the acquired businesses because customers have historically entered into such contracts for renewed and/or developmental support, although there can be no assurance that customers will do so in the future.

Adjusted Earnings Per Share

We use the term “adjusted earnings per share,” or “adjusted EPS,” to refer to GAAP earnings per share, excluding discontinued operations, amortization of intangible assets, inventory fair value adjustments related to business acquisitions, changes to the fair values assigned to contingent consideration, other costs related to business acquisitions, significant environmental charges, asset impairments, restructuring and contract termination charges, significant debt extinguishment charges, and significant tax credits, and including estimated revenue from contracts acquired in various acquisitions that will not be fully recognized due to business combination accounting rules. We also exclude adjustments for mark-to-market accounting on post-retirement benefits, therefore only our projected costs have been used to calculate our non-GAAP measure. Adjusted earnings per share is calculated by subtracting the items above included in adjusted gross margin, adjusted R&D expense, adjusted SG&A expense, restructuring and contract termination charges, the provision for taxes related to these items, and significant tax credits from GAAP earnings per share. We believe that this non-GAAP measure, when taken together with our GAAP financial measures, allows us and our investors to analyze the costs of producing and selling our products and the performance of our internal investments in technology and our internal operating structure, to evaluate the long-term profitability trends of our core operations and to calculate the underlying value of the core business on a dilutive share basis, which is a key measure of the value of the Company used by our management and we believe used by investors as well. Adjusted earnings per share also facilitates the overall analysis of the value of the Company and the core measure of the success of our operating business model as compared to prior and future periods and relative comparisons to our peers. We exclude discontinued operations, amortization of intangible assets, inventory fair value adjustments related to business acquisitions, changes to the fair values assigned to contingent consideration, other costs related to business acquisitions, adjustments for mark-to-market accounting on post-retirement benefits, significant environmental charges, asset impairments, restructuring and contract termination charges, significant debt extinguishment charges, and significant tax credits, as these items do not represent what we believe our investors consider to be costs of producing our products, investments in technology and production, and costs to support our internal operating structure, which could result in overstating or understating to our investors the performance of our operations. We include estimated revenue from contracts acquired with various acquisitions that will not be fully recognized due to business combination rules. Our GAAP revenue for the periods subsequent to our acquisitions does not reflect the full amount of revenue on such contracts that would have otherwise been recorded by the acquired businesses. The non-GAAP adjustment is intended to reflect the full amount of such revenue. We believe our investors will use this adjustment as a measure of the ongoing performance of the acquired businesses because customers have historically entered into such contracts for renewed and/or developmental support, although there can be no assurance that customers will do so in the future.

The fourth quarter tax effect on adjusted EPS for (i) discontinued operations was a benefit of $0.01 in 2013 and an expense of $0.00 in 2012, (ii) amortization of intangible assets was an expense of $0.08 in 2013 and an expense of $0.07 in 2012, (iii) significant environmental charges was an expense of $0.02 in 2013, (iv) asset impairments was an expense of $0.02 in 2013 and an expense of $0.23 in 2012, (v) restructuring and contract termination charges was an expense of $0.04 in 2013 and an expense of $0.01 in 2012, (vi) significant debt extinguishment charges was an expense of $0.05 in 2013, (vii) significant tax credits was a benefit of $0.06 in 2013, (viii) the estimated revenue from contracts acquired with various acquisitions that will not be fully recognized due to business combination accounting rules was an expense of $0.00 in 2013 and an expense of $0.01 in 2012, (ix) adjustments for mark-to-market accounting on post-retirement benefits was a benefit of $0.03 in 2013 and an expense of $0.08 in 2012. The fourth quarter tax effect on adjusted EPS for each of the remaining items (inventory fair value adjustments related to business acquisitions, changes to the fair values assigned to contingent consideration, and other costs related to business acquisitions) was $0.00 in both 2013 and 2012.

The full year tax effect on adjusted EPS through the fourth quarter for (i) discontinued operations was a benefit of $0.01 in 2013 and an expense of $0.01 in 2012, (ii) amortization of intangible assets was an expense of $0.28 in both 2013 and 2012, (iii) inventory fair value adjustments related to business acquisitions was an expense of $0.00 in 2013 and an expense of $0.02 in 2012, (iv) significant environmental charges was an expense of $0.02 in 2013, (v) asset impairments was an expense of $0.02 in 2013 and an expense of $0.23 in 2012, (vi) restructuring and contract termination charges was an expense of $0.10 in 2013 and an expense of $0.06 in 2012, (vii) significant debt extinguishment charges was an expense of $0.05 in 2013, (viii) significant tax credits was a benefit of $0.14 in 2013, (ix) the estimated revenue from contracts acquired with various acquisitions that will not be fully recognized due to business combination accounting rules was an expense of $0.02 in 2013 and an expense of $0.09 in 2012, (x) adjustments for mark-to-market accounting on post-retirement benefits was a benefit of $0.03 in 2013 and an expense of $0.08 in 2012. The full year tax effect on adjusted EPS through the fourth quarter for each of the remaining items (changes to the fair values assigned to contingent consideration and other costs related to business acquisitions) was $0.00 in both 2013 and 2012.

The tax effect for discontinued operations is calculated based on the authoritative guidance in the Financial Accounting Standards Board’s Accounting Standards Codification 740, Income Taxes. The tax effect for amortization of intangible assets, inventory fair value adjustments related to business acquisitions, changes to the fair values assigned to contingent consideration, other costs related to business acquisitions, significant environmental charges, asset impairments, adjustments for mark-to-market accounting on post-retirement benefits, restructuring and contract termination charges, significant debt extinguishment charges, significant tax credits, and the estimated revenue from contracts acquired with various acquisitions is calculated based on operational results and applicable jurisdictional law, which contemplates tax rates currently in effect to determine our tax provision.

* * *

The non-GAAP financial measures described above are not meant to be considered superior to, or a substitute for, our financial statements prepared in accordance with GAAP. There are material limitations associated with non-GAAP financial measures because they exclude charges that have an effect on our reported results and, therefore, should not be relied upon as the sole financial measures to evaluate our financial results. Management compensates and believes that investors should compensate for these limitations by viewing the non-GAAP financial measures in conjunction with the GAAP financial measures. In addition, the non-GAAP financial measures included in this earnings announcement may be different from, and therefore may not be comparable to, similar measures used by other companies.

Each of the non-GAAP financial measures listed above are also used by our management to evaluate our operating performance, communicate our financial results to our Board of Directors, benchmark our results against our historical performance and the performance of our peers, evaluate investment opportunities including acquisitions and discontinued operations, and determine the bonus payments for senior management and employees.

Contacts

Investor Relations:
PerkinElmer, Inc.
Tommy J. Thomas, CPA, 781-663-5889
tommy.thomas@perkinelmer.com
or
Media Contact:
PerkinElmer, Inc.
Fara Goldberg, 781-663-5699
fara.goldberg@perkinelmer.com

Contacts

Investor Relations:
PerkinElmer, Inc.
Tommy J. Thomas, CPA, 781-663-5889
tommy.thomas@perkinelmer.com
or
Media Contact:
PerkinElmer, Inc.
Fara Goldberg, 781-663-5699
fara.goldberg@perkinelmer.com